What drove the significant increase in net earnings for the quarter?

The significant increase in net earnings to $189.5 million was driven by strong revenue growth across all segments, particularly in Pharmaceutical Distribution, and a substantial reduction in merger-related costs compared to the prior year. Improved operating performance and effective cost management also contributed to the enhanced profitability.

What is the impact of merger-related costs on the company's financial performance?

While merger-related costs were notably high in the prior year ($87.5 million for the quarter), they decreased substantially to $10.7 million for the current quarter. This reduction indicates that the integration of past acquisitions is progressing, leading to fewer integration expenses and a positive impact on net earnings.

How is the company managing its liquidity and capital resources?

Cardinal Health's liquidity has improved, with cash and equivalents rising to $345.9 million. The company has also increased its commercial paper program capacity to $1 billion and its unsecured bank credit facility to $1.5 billion. Management believes these resources are adequate to fund anticipated expenditures, growth, and debt service requirements.

What are the key segments of Cardinal Health's business, and how are they performing?

Cardinal Health operates in three segments: Pharmaceutical Distribution, Pharmaceutical Services, and Medical-Surgical Products. The Pharmaceutical Distribution segment is the largest, showing strong revenue growth. Pharmaceutical Services also contributed positively with growth in drug delivery systems and packaging services. The Medical-Surgical Products segment saw increased sales across most product lines.

CAH 10-Q Quarterly Report Q3 FY2000 — Revenue, Net Income, EPS

Summary

Cardinal Health, Inc. reported strong growth in its third quarter ended March 31, 2000, with total revenue increasing by 15% to $7.47 billion year-over-year. Net earnings also saw significant growth, more than doubling to $189.5 million compared to $89.2 million in the prior year period. This performance was driven by a 16% increase in revenue for the nine-month period, indicating consistent expansion across the company's business segments. The company's strategic acquisitions and integration efforts, while incurring merger-related costs, appear to be contributing to overall operational improvements and revenue generation. Cardinal Health demonstrated robust cash flow from financing activities, bolstered by debt management and equity issuances, and maintained a strong liquidity position. The company reaffirmed its confidence in its capital resources to fund future growth and meet its financial obligations, positioning it for continued expansion in the healthcare distribution and services market.

Key Highlights

1Total revenue for the three months ended March 31, 2000, increased by 15% to $7.47 billion compared to $6.45 billion in the prior year.
2Net earnings for the three months ended March 31, 2000, significantly grew to $189.5 million, more than double the $89.2 million reported in the same period last year.
3The Pharmaceutical Distribution segment remains the largest contributor to revenue, showing a 20% increase in operating revenue for the quarter.
4The company reported a substantial increase in merchandise inventories, up to $4.30 billion from $2.94 billion in the prior year, reflecting anticipated business volume and vendor programs.
5Merger-related costs decreased significantly to $10.7 million for the quarter, down from $87.5 million in the prior year, indicating progress in integration efforts.
6Cash and equivalents increased to $345.9 million from $185.4 million in the prior year, demonstrating improved liquidity.
7Earnings per diluted share for the quarter rose to $0.67 from $0.31 in the prior year, reflecting strong profitability.

CARDINAL HEALTH INC Quarterly Report for Q3 Ended Mar 31, 2000

Summary

Key Highlights

Frequently Asked Questions